Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.
Patrick Peter John PhillipsCarole D MitnickJames D NeatonPayam NahidChristian LienhardtAndrew J NunnPublished in: PLoS medicine (2019)
In a Collection Review, Patrick Phillips and colleagues discuss developments in clinical trial design for the evaluation of TB therapeutics.